Andreas Haupt,Jürgen Dinges,Liliane Unger,Karsten Wicke,Robert Van Waterschoot,Karla Drescher,Ana Relo
申请号：
US14213169
公开号：
US09388148B2
申请日:
2014.03.14
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to novel acylaminocycloalkyl compounds, in particular to the compounds of the formula I as described herein and to their salts and N-oxides. The compounds possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of the dopamine D3 receptor.In formula I, the variables have the following meanings:m is 1 or 2,n is 1 or 2,A is selected from the group consisting of CH2, CH2CH2, CHFCH2 and CF2CH2,R1 is an oxygen containing cyclic radical selected such as C3-C6 cycloalkyl, which carries one or two oxygen containing radicals selected from the group consisting of OH, C1-C2-alkoxy, fluorinated C1-C2-alkoxy, and a carbonyl oxygen,R2 is selected from the group consisting of hydrogen, OH and fluorine,R3a is selected from the group consisting of hydrogen and methyl,R3b is selected from the group consisting of hydrogen and methyl,R4 is branched C4-C6 alkyl or branched fluorinated C4-C6 alkyl, andR5 is inter alia C1-C6 alkyl, fluorinated C1-C3 alkyl, C1-C2-alkoxy-C1-C4-alkyl, fluorinated C1-C2-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkyl, fluorinated hydroxy-C1-C4-alkyl, oxetanyl, fluorinated oxetanyl, oxolanyl, fluorinated oxolanyl, C3-C5 cycloalkyl, fluorinated C3-C5 cycloalkyl, etc.
